These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35652295)

  • 21. Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts.
    Mupo A; Seiler M; Sathiaseelan V; Pance A; Yang Y; Agrawal AA; Iorio F; Bautista R; Pacharne S; Tzelepis K; Manes N; Wright P; Papaemmanuil E; Kent DG; Campbell PC; Buonamici S; Bolli N; Vassiliou GS
    Leukemia; 2017 Mar; 31(3):720-727. PubMed ID: 27604819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage.
    Alsafadi S; Houy A; Battistella A; Popova T; Wassef M; Henry E; Tirode F; Constantinou A; Piperno-Neumann S; Roman-Roman S; Dutertre M; Stern MH
    Nat Commun; 2016 Feb; 7():10615. PubMed ID: 26842708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR editing of sftb-1/SF3B1 in Caenorhabditis elegans allows the identification of synthetic interactions with cancer-related mutations and the chemical inhibition of splicing.
    Serrat X; Kukhtar D; Cornes E; Esteve-Codina A; Benlloch H; Cecere G; Cerón J
    PLoS Genet; 2019 Oct; 15(10):e1008464. PubMed ID: 31634348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research.
    Samy A; Ozdemir MK; Alhajj R
    Sci Rep; 2023 Feb; 13(1):2704. PubMed ID: 36792691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis.
    Yang JY; Huo YM; Yang MW; Shen Y; Liu DJ; Fu XL; Tao LY; He RZ; Zhang JF; Hua R; Jiang SH; Sun YW; Liu W
    Mol Oncol; 2021 Nov; 15(11):3076-3090. PubMed ID: 33932092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation.
    Obeng EA; Chappell RJ; Seiler M; Chen MC; Campagna DR; Schmidt PJ; Schneider RK; Lord AM; Wang L; Gambe RG; McConkey ME; Ali AM; Raza A; Yu L; Buonamici S; Smith PG; Mullally A; Wu CJ; Fleming MD; Ebert BL
    Cancer Cell; 2016 Sep; 30(3):404-417. PubMed ID: 27622333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability.
    Liberante FG; Lappin K; Barros EM; Vohhodina J; Grebien F; Savage KI; Mills KI
    Sci Rep; 2019 Feb; 9(1):2678. PubMed ID: 30804405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms.
    Cazzola M; Rossi M; Malcovati L;
    Blood; 2013 Jan; 121(2):260-9. PubMed ID: 23160465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer-associated SF3B1-K700E mutation controls immune responses by regulating T
    Shi Y; Zhang W; Jia Q; Zhong X; Iyer P; Wu H; Yuan YC; Zhao Y; Zhang L; Wang L; Jia Z; Kuo YH; Sun Z
    Sci Adv; 2024 Sep; 10(38):eado4274. PubMed ID: 39303038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Silico Analysis of a Highly Mutated Gene in Cancer Provides Insight into Abnormal mRNA Splicing: Splicing Factor 3B Subunit 1
    Samy A; Suzek BE; Ozdemir MK; Sensoy O
    Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32354150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.
    Harbour JW; Roberson ED; Anbunathan H; Onken MD; Worley LA; Bowcock AM
    Nat Genet; 2013 Feb; 45(2):133-5. PubMed ID: 23313955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SF3B1 mutations in chronic lymphocytic leukemia.
    Wan Y; Wu CJ
    Blood; 2013 Jun; 121(23):4627-34. PubMed ID: 23568491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes.
    Visconte V; Rogers HJ; Singh J; Barnard J; Bupathi M; Traina F; McMahon J; Makishima H; Szpurka H; Jankowska A; Jerez A; Sekeres MA; Saunthararajah Y; Advani AS; Copelan E; Koseki H; Isono K; Padgett RA; Osman S; Koide K; O'Keefe C; Maciejewski JP; Tiu RV
    Blood; 2012 Oct; 120(16):3173-86. PubMed ID: 22826563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution.
    Lin CC; Hou HA; Chou WC; Kuo YY; Wu SJ; Liu CY; Chen CY; Tseng MH; Huang CF; Lee FY; Liu MC; Liu CW; Tang JL; Yao M; Huang SY; Hsu SC; Ko BS; Tsay W; Chen YC; Tien HF
    Am J Hematol; 2014 Aug; 89(8):E109-15. PubMed ID: 24723457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SF3B1 mutant myelodysplastic syndrome: Recent advances.
    Pellagatti A; Boultwood J
    Adv Biol Regul; 2021 Jan; 79():100776. PubMed ID: 33358369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degenerate minigene library analysis enables identification of altered branch point utilization by mutant splicing factor 3B1 (SF3B1).
    Gupta AK; Murthy T; Paul KV; Ramirez O; Fisher JB; Rao S; Rosenberg AB; Seelig G; Minella AC; Pillai MM
    Nucleic Acids Res; 2019 Jan; 47(2):970-980. PubMed ID: 30462273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptome sequencing reveals potential mechanism of cryptic 3' splice site selection in SF3B1-mutated cancers.
    DeBoever C; Ghia EM; Shepard PJ; Rassenti L; Barrett CL; Jepsen K; Jamieson CH; Carson D; Kipps TJ; Frazer KA
    PLoS Comput Biol; 2015 Mar; 11(3):e1004105. PubMed ID: 25768983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fanconi anemia FANCD2 and FANCI proteins regulate the nuclear dynamics of splicing factors.
    Moriel-Carretero M; Ovejero S; Gérus-Durand M; Vryzas D; Constantinou A
    J Cell Biol; 2017 Dec; 216(12):4007-4026. PubMed ID: 29030393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Splicing factor SF3B1K700E mutant dysregulates erythroid differentiation via aberrant alternative splicing of transcription factor TAL1.
    Jin S; Su H; Tran NT; Song J; Lu SS; Li Y; Huang S; Abdel-Wahab O; Liu Y; Zhao X
    PLoS One; 2017; 12(5):e0175523. PubMed ID: 28545085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts.
    Conte S; Katayama S; Vesterlund L; Karimi M; Dimitriou M; Jansson M; Mortera-Blanco T; Unneberg P; Papaemmanuil E; Sander B; Skoog T; Campbell P; Walfridsson J; Kere J; Hellström-Lindberg E
    Br J Haematol; 2015 Nov; 171(4):478-90. PubMed ID: 26255870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.